JLK Inc.
JPC-01K is an AI medical system that detects the area of prostate cancer using multiparametric MR images. The system is based on artificial neural networks to analyze the MR images of the prostate cancer patients. The system uses multiparametric MR images, T2, DWI, and DCE, as input and visualizes the location of the prostate cancer and their probability.
Information source: Vendor
Last updated: July 1, 2020

General Information

Product name JPC-01K
Company JLK Inc.
Subspeciality Abdomen
Modality MR
Disease targeted Prostate cancer
Key-features Prostate cancer detection
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion

Technical Specifications

Data characteristics
Population all prostate MR
Input multi sequence MR images (T2, DWI(Diffusion Weighted Image), DCE(Dynamic Contrast Enhanced))
Input format DICOM, JPG
Output Heatmap overlay, the probability of prostate cancer
Output format UI, Report
Integration Stand-alone third party application, Stand-alone webbased
Deployment Locally on dedicated hardware, Cloud-based, Hybrid solution
Trigger for analysis On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time 10 - 60 seconds


Certified, Class I , MDD
FDA No or not yet
Intended Use Statements
Intended use (according to CE)


Market presence
On market since 04-2019
Distribution channels
Countries present (clinical, non-research use) 2
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing model Pay-per-use, Subscription
Based on Number of users, Number of installations


Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers